Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs Testosterone in Obese Men with Hypogonadism
NCT03619330Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Dec 2014
- Primary completion
- Aug 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liraglutide in Hypogonadism and obesity, sponsored by University Medical Centre Ljubljana. Primary endpoints: Improvements of symptoms related to hypogonadism at 16 weeks and Change in testosterone level at 16 weeks. Started Dec 2014; status: completed.
02
Drugs
03
Conditions
Hypogonadismobesity
Beyond the preview
Go deeper on NCT03619330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03619330.